S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
OTCMKTS:BPSR

Organicell Regenerative Medicine (BPSR) Stock Forecast, Price & News

$0.01
0.00 (0.00%)
(As of 06/9/2023 ET)
Compare
Today's Range
$0.0112
$0.0120
50-Day Range
$0.0085
$0.0150
52-Week Range
$0.04
$0.63
Volume
32,465 shs
Average Volume
3.31 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BPSR stock logo

About Organicell Regenerative Medicine (OTCMKTS:BPSR) Stock

Biotech Products Services & Research, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. The firm also focuses on processing, distribution and supply of biologically processed cellular and tissue-based products developed from internally based research and development activities and also provides healthcare, anti-aging, and regenerative services. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Miami, FL.

Receive BPSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE daily newsletter.

BPSR Stock News Headlines

How A.I. Could Make Most 21st Century Diseases EXTINCT
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
Organicell Regenerative Medicine Inc (OCEL)
OCEL Organicell Regenerative Medicine, Inc.
Regenerative Medicine Market Report 2023-2033
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Organicell Regenerative Medicine Inc.
Organicell Starts Enrolling Long COVID Trial
Organicell Regenerative Medicine, Inc. (OCEL)
See More Headlines

BPSR Price History

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BPSR
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Albert MitraniAlbert Mitrani
    President, CEO, COO, Secretary & Treasurer
  • Ian T. BothwellIan T. Bothwell
    Chief Financial Officer & Director
  • Maria Ines MitraniMaria Ines Mitrani
    Director, Chief Science Officer & Vice President
  • George Craig Shapiro
    Director & Chief Medical Officer













BPSR Stock - Frequently Asked Questions

How have BPSR shares performed in 2023?

Organicell Regenerative Medicine's stock was trading at $0.0199 at the beginning of 2023. Since then, BPSR shares have decreased by 40.7% and is now trading at $0.0118.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Organicell Regenerative Medicine own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Organicell Regenerative Medicine investors own include Ciena (CIEN), Orbit Garant Drilling (OGD), Royal Caribbean Cruises (RCL), Synergy Pharmaceuticals (SGYP), Achillion Pharmaceuticals (ACHN), Aurora Cannabis (ACB), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS) and Abacus Property Group (ABP).

What is Organicell Regenerative Medicine's stock symbol?

Organicell Regenerative Medicine trades on the OTCMKTS under the ticker symbol "BPSR."

How do I buy shares of Organicell Regenerative Medicine?

Shares of BPSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Organicell Regenerative Medicine's stock price today?

One share of BPSR stock can currently be purchased for approximately $0.01.

How can I contact Organicell Regenerative Medicine?

Organicell Regenerative Medicine's mailing address is 4045 Sheridan Avenue,Suite 239, MIAMI, FL 33140, United States. The official website for the company is www.bespoketricycles.com. The company can be reached via phone at (888) 963-7881.

This page (OTCMKTS:BPSR) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -